Interpace Diagnostics (IDXG) Reports In-Line Q3 EPS

November 13, 2019 4:46 PM

Interpace Diagnostics (NASDAQ: IDXG) reported Q3 EPS of ($0.19), in-line with the analyst estimate of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found